Healthcare & Life Sciences
Mineralys Therapeutics
United Statesmineralystx.com/
Mineralys Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 3 tracked investors.
IPOseries-b
series-b
Stage
3
Investors
About Mineralys Therapeutics
Based in the United States, Mineralys Therapeutics is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Mineralys Therapeutics develops therapies targeting aldosterone dysregulation to improve outcomes in patients with hypertension, chronic kidney disease (CKD), and related cardio-renal-metabolic disorders.
Explore Mineralys Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.